ask="7.400"
ask_size="100"
average_daily_volume="32147"
bid="3.750"
bid_size="600"
book_value="2.160"
change="-0.001"
change_from_200_day_moving_average="1.300"
change_from_50_day_moving_average="0.998"
change_from_52_week_high="-2.351"
change_From_52_week_low="2.009"
change_in_percent="-0.020%"
close="5.049"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.800"
ebitda="-3.22M"
eps_estimate_current_year="-0.020"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.020"
ex_dividend_date="N/A"
float_shares="3212000"
high="5.049"
high_52_weeks="7.400"
last_trade_date="2/1/2017"
last_trade_price="5.049"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.945"
low_52_weeks="3.040"
market_capitalization="17.05M"
moving_average_200_day="3.749"
moving_average_50_day="4.051"
name="BiondVax Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="15.000"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+34.671%"
percent_change_from_50_day_moving_average="+24.643%"
percent_change_from_52_week_high="-31.770%"
percent_change_from_52_week_low="+66.086%"
previous_close="5.050"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.338"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="3377000"
short_ratio="8.570"
stock_exchange="NCM"
symbol="BVXV"
volume="8244"
weeks_range_52="3.040 - 7.400"
